Phase 2 Renal Cell Carcinoma, Clear Cell Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
Renal Cell Carcinoma, Clear Cell
M.D. Anderson Cancer Center15 enrolled5 locationsNCT06708949
Recruiting
Phase 2
NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
Renal Cell Carcinoma, Clear Cell, Somatic
Peter MacCallum Cancer Centre, Australia20 enrolled2 locationsNCT05024318
Terminated
Phase 2
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma
Metastatic Kidney CancerRenal Cell Carcinoma, Clear Cell
Australian and New Zealand Urogenital and Prostate Cancer Trials Group70 enrolled15 locationsACTRN12618000132246